38
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Global Incidence and Mortality of Gastric Cancer, 1980-2018

      research-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          Is the global burden of gastric cancer increasing in younger adults compared with older adults?

          Findings

          In this cohort study of data from 1980 to 2018 covering more than 1 million cases of gastric cancer, an increasing incidence of gastric cancer was observed in individuals younger than 40 years in a significant number of countries, including Sweden, the UK, and Ecuador.

          Meaning

          These findings suggest that the prevention of gastric cancer should become a priority in clinical guidelines and policy agendas to ameliorate its associated morbidity and mortality, especially among younger populations.

          Abstract

          Importance

          Gastric cancer is one of the most common cancers, with a high mortality-to-incidence ratio. It is uncertain whether developed nations may encounter an increasing burden of gastric cancer in young adults, as occurs for other cancers.

          Objectives

          To evaluate the incidence and mortality of gastric cancer and compare the global incidence trends between younger (<40 years) and older (≥40 years) populations.

          Design, Setting, and Participants

          This population-based cohort study analyzed data from global and national cancer registries, including data from 1980 to 2018, with at least 15 calendar years of incidence and mortality data. Data on age-standardized incidence and mortality rates of gastric cancer among 48 countries were retrieved from the Surveillance, Epidemiology, and End Results Program, the National Cancer Institute, the Nordic Cancer Registries, and the World Health Organization Mortality Database. The 10-year incidence trend of gastric cancer was assessed by age and sex. The 2018 GLOBOCAN database was used for reporting the global incidence and mortality of gastric cancer, the most recent data available at the time of analysis. Analyses were performed between January 10, 2020, and March 20, 2020.

          Main Outcomes and Measures

          The average annual percent change (AAPC) of the incidence and mortality trends as evaluated by joinpoint regression analysis.

          Results

          A total of 1 033 701 new cases of gastric cancer and 782 685 related deaths were reported in 2018. Overall, the incidence of gastric cancer decreased in 29 countries, and mortality decreased in 41 countries. The age-standardized incidence of gastric cancer decreased from a range of 2.6 to 59.1 in 1980 to a range of 2.5 to 56.8 in 2018 per 100 000 persons. The overall age-standardized mortality rate changed from a range of 1.3 to 25.8 in 1980 to a range of 1.5 to 18.5 in 2018 per 100 000 persons, but increasing mortality was observed in Thailand (female: AAPC, 5.30; 95% CI, 4.38-6.23; P < .001; male: AAPC, 3.92; 95% CI, 2.14-5.74; P < .001). The incidence of gastric cancer decreased in most regions among individuals 40 years or older and increased in populations younger than 40 years in several countries, including Sweden (male: AAPC, 13.92; 95% CI, 7.16-21.11; P = .001), Ecuador (female: AAPC, 6.05; 95% CI, 1.40-10.92; P = .02), and the UK (male: AAPC, 4.27; 95% CI, 0.15-8.55; P = .04; female: AAPC, 3.60; 95% CI, 3.59-3.61; P < .001).

          Conclusions and Relevance

          In this population-based cohort study, an increasing incidence of gastric cancer was observed in younger individuals in some countries, highlighting the need for more preventive strategies in younger populations. Future research should explore the reasons for these epidemiologic trends.

          Abstract

          This cohort study uses data from national and global cancer registries to evaluate the incidence and mortality of gastric cancer between 1980 and 2018 and compares the global incidence between younger and older populations.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

          This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found

            Global cancer statistics.

            The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors, particularly smoking, in economically developing countries. Based on the GLOBOCAN 2008 estimates, about 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008; of these, 56% of the cases and 64% of the deaths occurred in the economically developing world. Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among females, accounting for 23% of the total cancer cases and 14% of the cancer deaths. Lung cancer is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Breast cancer is now also the leading cause of cancer death among females in economically developing countries, a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Further, the mortality burden for lung cancer among females in developing countries is as high as the burden for cervical cancer, with each accounting for 11% of the total female cancer deaths. Although overall cancer incidence rates in the developing world are half those seen in the developed world in both sexes, the overall cancer mortality rates are generally similar. Cancer survival tends to be poorer in developing countries, most likely because of a combination of a late stage at diagnosis and limited access to timely and standard treatment. A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination (for liver and cervical cancers), and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake. Clinicians, public health professionals, and policy makers can play an active role in accelerating the application of such interventions globally.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Permutation tests for joinpoint regression with applications to cancer rates

                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                26 July 2021
                July 2021
                26 July 2021
                : 4
                : 7
                : e2118457
                Affiliations
                [1 ]The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong
                [2 ]Department of Global Health, School of Public Health, The Peking University, Beijing, China
                [3 ]School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
                [4 ]Department of Surgery, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong
                [5 ]Division of Gastroenterology, Department of Medicine, NYU Langone Health, New York, New York
                Author notes
                Article Information
                Accepted for Publication: May 22, 2021.
                Published: July 26, 2021. doi:10.1001/jamanetworkopen.2021.18457
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2021 Wong MCS et al. JAMA Network Open.
                Corresponding Author: Martin C. S. Wong, MD, MPH ( wong_martin@ 123456cuhk.edu.hk ), and Junjie Huang, MD, MSc ( junjie_huang@ 123456link.cuhk.edu.hk ), Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong 999077.
                Author Contributions: Drs Wong and Huang are co–first authors. Drs Wong and Huang had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Wong, P. S. F. Chan, S. M. Chan, Teoh.
                Acquisition, analysis, or interpretation of data: Huang, P. S. F. Chan, Choi, Lao, Teoh, Liang.
                Drafting of the manuscript: Wong, Huang, P. S. F. Chan, Choi.
                Critical revision of the manuscript for important intellectual content: Lao, S. M. Chan, Teoh, Liang.
                Statistical analysis: Huang, P. S. F. Chan.
                Administrative, technical, or material support: P. S. F. Chan, Choi.
                Supervision: Wong, S. M. Chan, Teoh.
                Conflict of Interest Disclosures: Dr Liang reported receiving grants from Epigenomics outside the submitted work. No other disclosures were reported.
                Additional Information: General support for this study was provided by Veeleah Lok, Hanyue Ding, and Xiao Chen. We acknowledge the help we received from Veeleah Lok, BSc, in modifying the visual arts of the figures and from Hanyue Ding, MPH, and MS Xiao Chen, MPH, for discussion during the literature search. They were all employed by the Jockey Club School of Public Health and Primary Care, Chinese University of Hong Kong. They were not compensated for their work outside their usual salaries.
                Article
                zoi210544
                10.1001/jamanetworkopen.2021.18457
                8314143
                34309666
                d784550b-7c79-49e9-87da-9a938d4d9906
                Copyright 2021 Wong MCS et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 1 December 2020
                : 22 May 2021
                Categories
                Research
                Original Investigation
                Featured
                Online Only
                Gastroenterology and Hepatology

                Comments

                Comment on this article